Trident Texofab (BOM:540726) said its board approved the conversion of about 1.6 million warrants into equity shares of 70 Indian rupees each, including a premium of 60 rupees per share, according to an Indian bourse filing on Monday.
The allotment, made to non-promoter public investors on promotional basis, follows the receipt of the balance payment of 82.7 million rupees.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.